Lennart Minthon focuses on Internal medicine, Alzheimer's disease, Dementia, Pathology and Neurology. His research in Internal medicine intersects with topics in Gastroenterology, Endocrinology and Oncology. The study incorporates disciplines such as Central nervous system disease, Surgery, Cognitive disorder and Activities of daily living in addition to Alzheimer's disease.
His studies in Dementia integrate themes in fields like Neuroscience and Case-control study. His work on Predictive value of tests, Cohort study and Prospective cohort study as part of general Pathology study is frequently connected to Context, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His work deals with themes such as Cohort, Disease, Parkinson's disease, Immunology and Vascular dementia, which intersect with Neurology.
Lennart Minthon spends much of his time researching Internal medicine, Dementia, Neurology, Alzheimer's disease and Cerebrospinal fluid. His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology and Oncology. He combines subjects such as Psychiatry and Parkinson's disease with his study of Dementia.
His work in Neurology covers topics such as Cognition which are related to areas like Audiology. His Alzheimer's disease research includes elements of Central nervous system disease, Degenerative disease, Cognitive disorder and Frontotemporal dementia. Cerebrospinal fluid is a subfield of Pathology that Lennart Minthon studies.
Lennart Minthon mostly deals with Internal medicine, Dementia, Neurology, Disease and Cerebrospinal fluid. The Internal medicine study combines topics in areas such as Endocrinology and Oncology. His Dementia research incorporates themes from Psychiatry, Geriatrics and Cohort.
Lennart Minthon has included themes like Cholinesterase, Cognition, Pulse wave velocity, Life expectancy and Prospective cohort study in his Neurology study. Lennart Minthon has researched Cerebrospinal fluid in several fields, including Biomarker, Amyloid beta and Gastroenterology. Lennart Minthon works mostly in the field of Alzheimer's disease, limiting it down to topics relating to Apolipoprotein E and, in certain cases, Allele and Pittsburgh compound B.
Cerebrospinal fluid, Dementia, Neurology, Pathology and Internal medicine are his primary areas of study. His research integrates issues of Tau protein, Cognitive test and Cohort in his study of Dementia. His Neurology research incorporates elements of Prospective cohort study and Hyperintensity.
His Pathology study combines topics from a wide range of disciplines, such as Biomarker and Oncology. His Internal medicine research integrates issues from Endocrinology, Posterior cingulate and Physical therapy. His Alzheimer's disease study incorporates themes from Gastroenterology, Apolipoprotein E, Flutemetamol F 18 and Genetic association.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
Oskar Hansson;Oskar Hansson;Henrik Zetterberg;Peder Buchhave;Peder Buchhave;Elisabet Londos;Elisabet Londos.
Lancet Neurology (2006)
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
Niklas Mattsson;Henrik Zetterberg;Oskar Hansson;Niels Andreasen.
JAMA (2009)
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Sandip Ray;Markus Britschgi;Charles Herbert;Yoshiko Takeda-Uchimura.
Nature Medicine (2007)
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
Pieter Jelle Visser;Pieter Jelle Visser;Frans Verhey;Dirk L Knol;Philip Scheltens.
Lancet Neurology (2009)
Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer Disease: Differences Between Early- and Late-Onset Alzheimer Disease and Stability During the Course of Disease
Niels Andreasen;Camilla Hesse;Pia Davidsson;Lennart Minthon.
JAMA Neurology (1999)
18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment : a phase 2 trial.
Rik Vandenberghe;Rik Vandenberghe;Koen Van Laere;Adrian Ivanoiu;Eric Salmon.
Annals of Neurology (2010)
Cerebrospinal Fluid Levels of β-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia.
Peder Buchhave;Lennart Minthon;Henrik Zetterberg;Åsa K. Wallin.
Archives of General Psychiatry (2012)
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
Dag Aarsland;Dag Aarsland;Clive Ballard;Zuzana Walker;Zuzana Walker;Fredrik Bostrom.
Lancet Neurology (2009)
Interleukin-6 Is Elevated in the Cerebrospinal Fluid of Suicide Attempters and Related to Symptom Severity
Daniel Lindqvist;Shorena Janelidze;Peter Hagell;Sophie Erhardt.
Biological Psychiatry (2009)
Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study
Bengt Winblad;Lena Kilander;Sture Eriksson;Lennart Minthon.
The Lancet (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Gothenburg
University of Gothenburg
Lund University
Lund University
Université Paris Cité
Karolinska University Hospital
University of Gothenburg
Maastricht University
Karolinska Institute
Aristotle University of Thessaloniki
University of Western Australia
Jilin University
University of Southern Queensland
Rensselaer Polytechnic Institute
Vrije Universiteit Amsterdam
Beijing Institute of Technology
Zhejiang University
Yale University
Hokkaido University
University of Pennsylvania
University of Michigan–Ann Arbor
University of Wisconsin–Madison
Seattle Children's Hospital
University of Edinburgh
University of Minnesota
Harvard University